Babcock & Wilcox Enterprises Inc buy krebskrebs
Start price
28.04.20
/
50%
€0.86
Target price
04.11.21
€0.90
Performance (%)
666.08%
End price
05.11.21
€6.55
Summary
This prediction ended on 05.11.21 with a price of €6.55. With a performance of 666.08% the BUY prediction by krebskrebs was a big success. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Babcock & Wilcox Enterprises Inc | -8.805% | -8.805% | 603.883% | 18.852% |
| iShares Core DAX® | 0.024% | 0.583% | 11.674% | 61.622% |
| iShares Nasdaq 100 | 1.740% | -2.061% | 4.180% | 88.706% |
| iShares Nikkei 225® | 0.428% | 10.487% | 29.994% | 67.054% |
| iShares S&P 500 | 1.329% | 0.140% | 3.333% | 60.858% |
Comments by krebskrebs for this prediction
In the thread Babcock & Wilcox Enterprises Inc diskutieren
In the thread Trading Babcock & Wilcox Enterprises Inc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten